Investor profile
Sarah Schram
Private equity, Venture debt & Investment Analyst (Biotechnology/Pharma) at UBS
Sarah Schram is an Investment Analyst (Biotechnology/Pharma) at UBS, whose known portfolio counts 23 companies.
Is Sarah Schram a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Investment Analyst (Biotechnology/Pharma) at UBS, whose known portfolio counts 23 companies
- LIME
- Pagaya
- Bukalapak
- Evolv Technology
- Azul SA
- Voyage Foods
- iCapital
- Cloud9 Technologies
- Rockley Photonics
- Humacyte
- Dodge Data & Analytics
- MTS Markets International
- and 11 more
Investor Profile
UBS appears in Growth, Late-Stage and Seed rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Sarah Schram is worth approaching.
Colleagues at UBS
Showing 20 of 53
Rodrigo Garcia
Independent Board Director (Funds)
San Diego, United States
Mark Mackenzie
Managing Director
New York, United States
Abdul Gafoor Khan
Employee
Hyderabad, India
Kevin Brunner
Managing Partner
Zürich, Switzerland
Elane Drussman
Venture Partner
Boca Raton, United States
Chris Cook
Managing Director
New York, United States
Christopher Pitzak
Managing Director
Newport Beach, United States
Marcus Denter Silva
Venture Capital
Zürich, Switzerland
Anastasiya Kurenia
Executive Director
United Kingdom
Philip Akram
Director UBS Next
Zürich, Switzerland
Michael Rieser
Director
Basel, Switzerland
Rustam Moman
Managing Partner
London, United Kingdom
Bruno Hallak
Managing Director
Paris, France
Riona· Mona
Angel lnvestments
Paris, France
Eleanor Ward
Investment Banking Analyst
New York, United States
Maxime Léon Carpy
Wholesale & Partnerships
Zürich, Switzerland
Alec Osborn
Strategic Ventures at UBS
London, United Kingdom
Dan Arnold
Investment Analyst
United States
Connie Hsieh
V.P.
Taiwan
Mona Riona
Angel lnvestments
Paris, France
Frequently asked questions
Who is Sarah Schram?
Sarah Schram is a private equity investor and venture debt investor based in Chicago, Illinois, United States, listed as Investment Analyst (Biotechnology/Pharma) at UBS. The known portfolio of that firm counts 23 companies. That portfolio belongs to the firm, not to Sarah Schram personally.
What stage does Sarah Schram invest at?
UBS appears in Growth, Late-Stage and Seed rounds across its known deals, and Sarah Schram is listed there as Investment Analyst (Biotechnology/Pharma). Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Sarah Schram listed at?
Sarah Schram is listed as Investment Analyst (Biotechnology/Pharma) at UBS. 53 other people in the database share a firm with Sarah Schram.
How do I contact Sarah Schram?
An email address, a phone number and a LinkedIn page are on file for Sarah Schram. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 6 September 2026 · How this data is built · Report a correction or request removal